Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does BUPROPION Cause Product dose omission in error? 20 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Product dose omission in error have been filed in association with BUPROPION (Bupropion Hydrochloride (XL)). This represents 0.1% of all adverse event reports for BUPROPION.

20
Reports of Product dose omission in error with BUPROPION
0.1%
of all BUPROPION reports
0
Deaths
2
Hospitalizations

How Dangerous Is Product dose omission in error From BUPROPION?

Of the 20 reports, 2 (10.0%) required hospitalization, and 1 (5.0%) were considered life-threatening.

Is Product dose omission in error Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for BUPROPION. However, 20 reports have been filed with the FAERS database.

What Other Side Effects Does BUPROPION Cause?

Completed suicide (5,095) Drug ineffective (3,991) Toxicity to various agents (3,837) Depression (2,486) Overdose (2,357) Headache (2,323) Anxiety (2,145) Intentional overdose (2,103) Drug hypersensitivity (1,967) Seizure (1,894)

What Other Drugs Cause Product dose omission in error?

DUPILUMAB (7,586) TOFACITINIB (2,461) LENALIDOMIDE (618) PALBOCICLIB (592) DIROXIMEL (481) ABALOPARATIDE (457) NIRAPARIB (428) RUXOLITINIB (425) TERIFLUNOMIDE (371) DIMETHYL (308)

Which BUPROPION Alternatives Have Lower Product dose omission in error Risk?

BUPROPION vs BUPROPION HYDROBROMIDE BUPROPION vs BUPROPION\DEXTROMETHORPHAN HYDROBROMIDE BUPROPION vs BUPROPION\NALTREXONE BUPROPION vs BUROSUMAB BUPROPION vs BUROSUMAB-TWZA

Related Pages

BUPROPION Full Profile All Product dose omission in error Reports All Drugs Causing Product dose omission in error BUPROPION Demographics